(Q38944200)

7 September 2017

Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients (English)

1 reference

7 September 2017

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jochen Utikal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Huanhuan Jiang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ludmila Umansky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Philipp Beckhove

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Torsten J Schulze

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Viktor Umansky

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

12 November 2014

1 reference

International Journal of Cancer

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

2352-2360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25353097%20AND%20SRC:MED&resulttype=core&format=json

International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?

7 June 2020

cites work

1 reference

Human T cell responses against melanoma

21 January 2018

1 reference

Immunotherapy for advanced melanoma: fulfilling the promise

21 January 2018

1 reference

CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients

21 January 2018

1 reference

Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment

21 January 2018

1 reference

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

Melanoma-induced immunosuppression and its neutralization

21 January 2018

1 reference

Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?

21 January 2018

1 reference

Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance

21 January 2018

1 reference

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

21 January 2018

1 reference

Myeloid-derived suppressor cell heterogeneity in human cancers

21 January 2018

1 reference

On the armament and appearances of human myeloid-derived suppressor cells

21 January 2018

1 reference

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

21 January 2018

1 reference

Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells

21 January 2018

1 reference

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

21 January 2018

1 reference

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

How regulatory T cells work

21 January 2018

1 reference

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

21 January 2018

1 reference

New insights into chronic inflammation-induced immunosuppression.

21 January 2018

1 reference

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

Melanoma and innate immunity--aActive inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines.

21 January 2018

1 reference

Chemokines in cancer related inflammation

21 January 2018

1 reference

Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro

21 January 2018

1 reference

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

21 January 2018

1 reference

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment

21 January 2018

1 reference

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

21 January 2018

1 reference

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

21 January 2018

1 reference

The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression

21 January 2018

1 reference

21 January 2018

1 reference

Inflammation and cancer: an ancient link with novel potentials.

21 January 2018

1 reference

Clinical Implications of VEGF, TGF-β1, and IL-1β in Patients with Advanced Non-small Cell Lung Cancer

21 January 2018

1 reference

IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9

21 January 2018

1 reference

Immunological and inflammatory functions of the interleukin-1 family

21 January 2018

1 reference

Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?

21 January 2018

1 reference

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

21 January 2018

1 reference

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

The two faces of interferon-γ in cancer

21 January 2018

1 reference

Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells

21 January 2018

1 reference

The good and the bad of chemokines/chemokine receptors in melanoma

21 January 2018

1 reference

CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas

21 January 2018

1 reference

The role of CXCR3 and CXCR4 in colorectal cancer metastasis.

21 January 2018

1 reference

K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5.

21 January 2018

1 reference

Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients

21 January 2018

1 reference